Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study

Objectives To describe the variation in approaches to surgical and antibiotic treatment for first cerebrospinal fluid (CSF) shunt infection and adherence to Infectious Diseases Society of America (IDSA) guidelines. Study design We conducted a prospective cohort study of children undergoing treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2016-12, Vol.179, p.185-191.e2
Hauptverfasser: Simon, Tamara D., MD, MSPH, Kronman, Matthew P., MD, MSCE, Whitlock, Kathryn B., MS, Gove, Nancy, PhD, Browd, Samuel R., MD, PhD, Holubkov, Richard, PhD, Kestle, John R.W., MD, Kulkarni, Abhaya V., MD, PhD, Langley, Marcie, BS, Limbrick, David D., MD, PhD, Luerssen, Thomas G., MD, Oakes, Jerry, MD, Riva-Cambrin, Jay, MD, MSc, Rozzelle, Curtis, MD, Shannon, Chevis, DrPH, Tamber, Mandeep, MD, PhD, Wellons, John C., MD, MSPH, Whitehead, William E., MD, MPH, Mayer-Hamblett, Nicole, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 191.e2
container_issue
container_start_page 185
container_title The Journal of pediatrics
container_volume 179
creator Simon, Tamara D., MD, MSPH
Kronman, Matthew P., MD, MSCE
Whitlock, Kathryn B., MS
Gove, Nancy, PhD
Browd, Samuel R., MD, PhD
Holubkov, Richard, PhD
Kestle, John R.W., MD
Kulkarni, Abhaya V., MD, PhD
Langley, Marcie, BS
Limbrick, David D., MD, PhD
Luerssen, Thomas G., MD
Oakes, Jerry, MD
Riva-Cambrin, Jay, MD, MSc
Rozzelle, Curtis, MD
Shannon, Chevis, DrPH
Tamber, Mandeep, MD, PhD
Wellons, John C., MD, MSPH
Whitehead, William E., MD, MPH
Mayer-Hamblett, Nicole, PhD
description Objectives To describe the variation in approaches to surgical and antibiotic treatment for first cerebrospinal fluid (CSF) shunt infection and adherence to Infectious Diseases Society of America (IDSA) guidelines. Study design We conducted a prospective cohort study of children undergoing treatment for first CSF infection at 7 Hydrocephalus Clinical Research Network hospitals from April 2008 through December 2012. Univariate analyses were performed to describe the study population. Results A total of 151 children underwent treatment for first CSF shunt-related infection. Most children had undergone initial CSF shunt placement before the age of 6 months (n =  98, 65%). Median time to infection after shunt surgery was 28 days (IQR 15-52 days). Surgical management was most often shunt removal with interim external ventricular drain placement, followed by new shunt insertion (n = 122, 81%). Median time from first negative CSF culture to final surgical procedure was 14 days (IQR 10-21 days). Median duration of intravenous (IV) antibiotic use duration was 19 days (IQR 12-28 days). For 84 infections addressed by IDSA guidelines, 7 (8%) met guidelines and 61 (73%) had longer duration of IV antibiotic use than recommended. Conclusions Surgical treatment for infection frequently adheres to IDSA guidelines of shunt removal with external ventricular drain placement followed by new shunt insertion. However, duration of IV antibiotic use in CSF shunt infection treatment was consistently longer than recommended by the 2004 IDSA guidelines.
doi_str_mv 10.1016/j.jpeds.2016.08.094
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5123958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0022347616308770</els_id><sourcerecordid>1835390520</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-31a452f5fe4bd70dfd491610d2441cfd3955ab57fca7fd34390fc8f0a856aec53</originalsourceid><addsrcrecordid>eNqFkl-LEzEUxQdR3Lr6CQTJoy8zJpPJ_BFcWIrVwi4rVH0NmeRmm3Ga1CRT6Lsf3Iyti_riUzjkd-7NvSdZ9pLggmBSvxmKYQ8qFGUSBW4L3FWPsgXBXZPXLaWPswXGZZnTqqkvsmchDBgnBOOn2UXZ1F1Z1XSR_fgqvBG9GU08ImPRrbDiHnZgI3IarYwPES3BQ-9d2BsrRrQaJ6PQZjslZG01yGicfYuu0acZmeUB0O00RpOvbYgmTjOQjHd9AH8QZ7V0W-cj2sRJHZ9nT7QYA7w4n5fZl9X7z8uP-c3dh_Xy-iaXjFQxp0RUrNRMQ9WrBiutqo7UBKuyqojUinaMiZ41WoomqYp2WMtWY9GyWoBk9DK7OtXdT_0OlExTejHyvTc74Y_cCcP_vrFmy-_dgTNSpuJtKvD6XMC77xOEyHcmSBhHYcFNgZOWstSVlTih9ITKtJbgQT-0IZjP-fGB_8qPz_lx3PIUTnK9-vOFD57fgSXg3QmAtKeDAc-DNGAlKOPT7rly5j8Nrv7xy9FYI8X4DY4QBjf5lE6ahIeSY76Zv9D8g0hNcds0mP4ER5PGUQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1835390520</pqid></control><display><type>article</type><title>Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Simon, Tamara D., MD, MSPH ; Kronman, Matthew P., MD, MSCE ; Whitlock, Kathryn B., MS ; Gove, Nancy, PhD ; Browd, Samuel R., MD, PhD ; Holubkov, Richard, PhD ; Kestle, John R.W., MD ; Kulkarni, Abhaya V., MD, PhD ; Langley, Marcie, BS ; Limbrick, David D., MD, PhD ; Luerssen, Thomas G., MD ; Oakes, Jerry, MD ; Riva-Cambrin, Jay, MD, MSc ; Rozzelle, Curtis, MD ; Shannon, Chevis, DrPH ; Tamber, Mandeep, MD, PhD ; Wellons, John C., MD, MSPH ; Whitehead, William E., MD, MPH ; Mayer-Hamblett, Nicole, PhD</creator><creatorcontrib>Simon, Tamara D., MD, MSPH ; Kronman, Matthew P., MD, MSCE ; Whitlock, Kathryn B., MS ; Gove, Nancy, PhD ; Browd, Samuel R., MD, PhD ; Holubkov, Richard, PhD ; Kestle, John R.W., MD ; Kulkarni, Abhaya V., MD, PhD ; Langley, Marcie, BS ; Limbrick, David D., MD, PhD ; Luerssen, Thomas G., MD ; Oakes, Jerry, MD ; Riva-Cambrin, Jay, MD, MSc ; Rozzelle, Curtis, MD ; Shannon, Chevis, DrPH ; Tamber, Mandeep, MD, PhD ; Wellons, John C., MD, MSPH ; Whitehead, William E., MD, MPH ; Mayer-Hamblett, Nicole, PhD ; Hydrocephalus Clinical Research Network (HCRN)</creatorcontrib><description>Objectives To describe the variation in approaches to surgical and antibiotic treatment for first cerebrospinal fluid (CSF) shunt infection and adherence to Infectious Diseases Society of America (IDSA) guidelines. Study design We conducted a prospective cohort study of children undergoing treatment for first CSF infection at 7 Hydrocephalus Clinical Research Network hospitals from April 2008 through December 2012. Univariate analyses were performed to describe the study population. Results A total of 151 children underwent treatment for first CSF shunt-related infection. Most children had undergone initial CSF shunt placement before the age of 6 months (n =  98, 65%). Median time to infection after shunt surgery was 28 days (IQR 15-52 days). Surgical management was most often shunt removal with interim external ventricular drain placement, followed by new shunt insertion (n = 122, 81%). Median time from first negative CSF culture to final surgical procedure was 14 days (IQR 10-21 days). Median duration of intravenous (IV) antibiotic use duration was 19 days (IQR 12-28 days). For 84 infections addressed by IDSA guidelines, 7 (8%) met guidelines and 61 (73%) had longer duration of IV antibiotic use than recommended. Conclusions Surgical treatment for infection frequently adheres to IDSA guidelines of shunt removal with external ventricular drain placement followed by new shunt insertion. However, duration of IV antibiotic use in CSF shunt infection treatment was consistently longer than recommended by the 2004 IDSA guidelines.</description><identifier>ISSN: 0022-3476</identifier><identifier>EISSN: 1097-6833</identifier><identifier>DOI: 10.1016/j.jpeds.2016.08.094</identifier><identifier>PMID: 27692463</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>antibiotic ; Bacterial Infections - etiology ; Bacterial Infections - therapy ; cerebrospinal ; Cerebrospinal Fluid Shunts - adverse effects ; Child, Preschool ; Cohort Studies ; Female ; Guideline Adherence - statistics &amp; numerical data ; Humans ; Infant ; Infant, Newborn ; infection ; Male ; Pediatrics ; Postoperative Complications - etiology ; Postoperative Complications - therapy ; Prospective Studies ; shunt ; treatment</subject><ispartof>The Journal of pediatrics, 2016-12, Vol.179, p.185-191.e2</ispartof><rights>Elsevier Inc.</rights><rights>2016 Elsevier Inc.</rights><rights>Copyright © 2016 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-31a452f5fe4bd70dfd491610d2441cfd3955ab57fca7fd34390fc8f0a856aec53</citedby><cites>FETCH-LOGICAL-c514t-31a452f5fe4bd70dfd491610d2441cfd3955ab57fca7fd34390fc8f0a856aec53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jpeds.2016.08.094$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,315,781,785,886,3551,27929,27930,46000</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27692463$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Simon, Tamara D., MD, MSPH</creatorcontrib><creatorcontrib>Kronman, Matthew P., MD, MSCE</creatorcontrib><creatorcontrib>Whitlock, Kathryn B., MS</creatorcontrib><creatorcontrib>Gove, Nancy, PhD</creatorcontrib><creatorcontrib>Browd, Samuel R., MD, PhD</creatorcontrib><creatorcontrib>Holubkov, Richard, PhD</creatorcontrib><creatorcontrib>Kestle, John R.W., MD</creatorcontrib><creatorcontrib>Kulkarni, Abhaya V., MD, PhD</creatorcontrib><creatorcontrib>Langley, Marcie, BS</creatorcontrib><creatorcontrib>Limbrick, David D., MD, PhD</creatorcontrib><creatorcontrib>Luerssen, Thomas G., MD</creatorcontrib><creatorcontrib>Oakes, Jerry, MD</creatorcontrib><creatorcontrib>Riva-Cambrin, Jay, MD, MSc</creatorcontrib><creatorcontrib>Rozzelle, Curtis, MD</creatorcontrib><creatorcontrib>Shannon, Chevis, DrPH</creatorcontrib><creatorcontrib>Tamber, Mandeep, MD, PhD</creatorcontrib><creatorcontrib>Wellons, John C., MD, MSPH</creatorcontrib><creatorcontrib>Whitehead, William E., MD, MPH</creatorcontrib><creatorcontrib>Mayer-Hamblett, Nicole, PhD</creatorcontrib><creatorcontrib>Hydrocephalus Clinical Research Network (HCRN)</creatorcontrib><title>Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study</title><title>The Journal of pediatrics</title><addtitle>J Pediatr</addtitle><description>Objectives To describe the variation in approaches to surgical and antibiotic treatment for first cerebrospinal fluid (CSF) shunt infection and adherence to Infectious Diseases Society of America (IDSA) guidelines. Study design We conducted a prospective cohort study of children undergoing treatment for first CSF infection at 7 Hydrocephalus Clinical Research Network hospitals from April 2008 through December 2012. Univariate analyses were performed to describe the study population. Results A total of 151 children underwent treatment for first CSF shunt-related infection. Most children had undergone initial CSF shunt placement before the age of 6 months (n =  98, 65%). Median time to infection after shunt surgery was 28 days (IQR 15-52 days). Surgical management was most often shunt removal with interim external ventricular drain placement, followed by new shunt insertion (n = 122, 81%). Median time from first negative CSF culture to final surgical procedure was 14 days (IQR 10-21 days). Median duration of intravenous (IV) antibiotic use duration was 19 days (IQR 12-28 days). For 84 infections addressed by IDSA guidelines, 7 (8%) met guidelines and 61 (73%) had longer duration of IV antibiotic use than recommended. Conclusions Surgical treatment for infection frequently adheres to IDSA guidelines of shunt removal with external ventricular drain placement followed by new shunt insertion. However, duration of IV antibiotic use in CSF shunt infection treatment was consistently longer than recommended by the 2004 IDSA guidelines.</description><subject>antibiotic</subject><subject>Bacterial Infections - etiology</subject><subject>Bacterial Infections - therapy</subject><subject>cerebrospinal</subject><subject>Cerebrospinal Fluid Shunts - adverse effects</subject><subject>Child, Preschool</subject><subject>Cohort Studies</subject><subject>Female</subject><subject>Guideline Adherence - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Infant</subject><subject>Infant, Newborn</subject><subject>infection</subject><subject>Male</subject><subject>Pediatrics</subject><subject>Postoperative Complications - etiology</subject><subject>Postoperative Complications - therapy</subject><subject>Prospective Studies</subject><subject>shunt</subject><subject>treatment</subject><issn>0022-3476</issn><issn>1097-6833</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkl-LEzEUxQdR3Lr6CQTJoy8zJpPJ_BFcWIrVwi4rVH0NmeRmm3Ga1CRT6Lsf3Iyti_riUzjkd-7NvSdZ9pLggmBSvxmKYQ8qFGUSBW4L3FWPsgXBXZPXLaWPswXGZZnTqqkvsmchDBgnBOOn2UXZ1F1Z1XSR_fgqvBG9GU08ImPRrbDiHnZgI3IarYwPES3BQ-9d2BsrRrQaJ6PQZjslZG01yGicfYuu0acZmeUB0O00RpOvbYgmTjOQjHd9AH8QZ7V0W-cj2sRJHZ9nT7QYA7w4n5fZl9X7z8uP-c3dh_Xy-iaXjFQxp0RUrNRMQ9WrBiutqo7UBKuyqojUinaMiZ41WoomqYp2WMtWY9GyWoBk9DK7OtXdT_0OlExTejHyvTc74Y_cCcP_vrFmy-_dgTNSpuJtKvD6XMC77xOEyHcmSBhHYcFNgZOWstSVlTih9ITKtJbgQT-0IZjP-fGB_8qPz_lx3PIUTnK9-vOFD57fgSXg3QmAtKeDAc-DNGAlKOPT7rly5j8Nrv7xy9FYI8X4DY4QBjf5lE6ahIeSY76Zv9D8g0hNcds0mP4ER5PGUQ</recordid><startdate>20161201</startdate><enddate>20161201</enddate><creator>Simon, Tamara D., MD, MSPH</creator><creator>Kronman, Matthew P., MD, MSCE</creator><creator>Whitlock, Kathryn B., MS</creator><creator>Gove, Nancy, PhD</creator><creator>Browd, Samuel R., MD, PhD</creator><creator>Holubkov, Richard, PhD</creator><creator>Kestle, John R.W., MD</creator><creator>Kulkarni, Abhaya V., MD, PhD</creator><creator>Langley, Marcie, BS</creator><creator>Limbrick, David D., MD, PhD</creator><creator>Luerssen, Thomas G., MD</creator><creator>Oakes, Jerry, MD</creator><creator>Riva-Cambrin, Jay, MD, MSc</creator><creator>Rozzelle, Curtis, MD</creator><creator>Shannon, Chevis, DrPH</creator><creator>Tamber, Mandeep, MD, PhD</creator><creator>Wellons, John C., MD, MSPH</creator><creator>Whitehead, William E., MD, MPH</creator><creator>Mayer-Hamblett, Nicole, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20161201</creationdate><title>Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study</title><author>Simon, Tamara D., MD, MSPH ; Kronman, Matthew P., MD, MSCE ; Whitlock, Kathryn B., MS ; Gove, Nancy, PhD ; Browd, Samuel R., MD, PhD ; Holubkov, Richard, PhD ; Kestle, John R.W., MD ; Kulkarni, Abhaya V., MD, PhD ; Langley, Marcie, BS ; Limbrick, David D., MD, PhD ; Luerssen, Thomas G., MD ; Oakes, Jerry, MD ; Riva-Cambrin, Jay, MD, MSc ; Rozzelle, Curtis, MD ; Shannon, Chevis, DrPH ; Tamber, Mandeep, MD, PhD ; Wellons, John C., MD, MSPH ; Whitehead, William E., MD, MPH ; Mayer-Hamblett, Nicole, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-31a452f5fe4bd70dfd491610d2441cfd3955ab57fca7fd34390fc8f0a856aec53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>antibiotic</topic><topic>Bacterial Infections - etiology</topic><topic>Bacterial Infections - therapy</topic><topic>cerebrospinal</topic><topic>Cerebrospinal Fluid Shunts - adverse effects</topic><topic>Child, Preschool</topic><topic>Cohort Studies</topic><topic>Female</topic><topic>Guideline Adherence - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Infant</topic><topic>Infant, Newborn</topic><topic>infection</topic><topic>Male</topic><topic>Pediatrics</topic><topic>Postoperative Complications - etiology</topic><topic>Postoperative Complications - therapy</topic><topic>Prospective Studies</topic><topic>shunt</topic><topic>treatment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Simon, Tamara D., MD, MSPH</creatorcontrib><creatorcontrib>Kronman, Matthew P., MD, MSCE</creatorcontrib><creatorcontrib>Whitlock, Kathryn B., MS</creatorcontrib><creatorcontrib>Gove, Nancy, PhD</creatorcontrib><creatorcontrib>Browd, Samuel R., MD, PhD</creatorcontrib><creatorcontrib>Holubkov, Richard, PhD</creatorcontrib><creatorcontrib>Kestle, John R.W., MD</creatorcontrib><creatorcontrib>Kulkarni, Abhaya V., MD, PhD</creatorcontrib><creatorcontrib>Langley, Marcie, BS</creatorcontrib><creatorcontrib>Limbrick, David D., MD, PhD</creatorcontrib><creatorcontrib>Luerssen, Thomas G., MD</creatorcontrib><creatorcontrib>Oakes, Jerry, MD</creatorcontrib><creatorcontrib>Riva-Cambrin, Jay, MD, MSc</creatorcontrib><creatorcontrib>Rozzelle, Curtis, MD</creatorcontrib><creatorcontrib>Shannon, Chevis, DrPH</creatorcontrib><creatorcontrib>Tamber, Mandeep, MD, PhD</creatorcontrib><creatorcontrib>Wellons, John C., MD, MSPH</creatorcontrib><creatorcontrib>Whitehead, William E., MD, MPH</creatorcontrib><creatorcontrib>Mayer-Hamblett, Nicole, PhD</creatorcontrib><creatorcontrib>Hydrocephalus Clinical Research Network (HCRN)</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Journal of pediatrics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Simon, Tamara D., MD, MSPH</au><au>Kronman, Matthew P., MD, MSCE</au><au>Whitlock, Kathryn B., MS</au><au>Gove, Nancy, PhD</au><au>Browd, Samuel R., MD, PhD</au><au>Holubkov, Richard, PhD</au><au>Kestle, John R.W., MD</au><au>Kulkarni, Abhaya V., MD, PhD</au><au>Langley, Marcie, BS</au><au>Limbrick, David D., MD, PhD</au><au>Luerssen, Thomas G., MD</au><au>Oakes, Jerry, MD</au><au>Riva-Cambrin, Jay, MD, MSc</au><au>Rozzelle, Curtis, MD</au><au>Shannon, Chevis, DrPH</au><au>Tamber, Mandeep, MD, PhD</au><au>Wellons, John C., MD, MSPH</au><au>Whitehead, William E., MD, MPH</au><au>Mayer-Hamblett, Nicole, PhD</au><aucorp>Hydrocephalus Clinical Research Network (HCRN)</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study</atitle><jtitle>The Journal of pediatrics</jtitle><addtitle>J Pediatr</addtitle><date>2016-12-01</date><risdate>2016</risdate><volume>179</volume><spage>185</spage><epage>191.e2</epage><pages>185-191.e2</pages><issn>0022-3476</issn><eissn>1097-6833</eissn><abstract>Objectives To describe the variation in approaches to surgical and antibiotic treatment for first cerebrospinal fluid (CSF) shunt infection and adherence to Infectious Diseases Society of America (IDSA) guidelines. Study design We conducted a prospective cohort study of children undergoing treatment for first CSF infection at 7 Hydrocephalus Clinical Research Network hospitals from April 2008 through December 2012. Univariate analyses were performed to describe the study population. Results A total of 151 children underwent treatment for first CSF shunt-related infection. Most children had undergone initial CSF shunt placement before the age of 6 months (n =  98, 65%). Median time to infection after shunt surgery was 28 days (IQR 15-52 days). Surgical management was most often shunt removal with interim external ventricular drain placement, followed by new shunt insertion (n = 122, 81%). Median time from first negative CSF culture to final surgical procedure was 14 days (IQR 10-21 days). Median duration of intravenous (IV) antibiotic use duration was 19 days (IQR 12-28 days). For 84 infections addressed by IDSA guidelines, 7 (8%) met guidelines and 61 (73%) had longer duration of IV antibiotic use than recommended. Conclusions Surgical treatment for infection frequently adheres to IDSA guidelines of shunt removal with external ventricular drain placement followed by new shunt insertion. However, duration of IV antibiotic use in CSF shunt infection treatment was consistently longer than recommended by the 2004 IDSA guidelines.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>27692463</pmid><doi>10.1016/j.jpeds.2016.08.094</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3476
ispartof The Journal of pediatrics, 2016-12, Vol.179, p.185-191.e2
issn 0022-3476
1097-6833
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5123958
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects antibiotic
Bacterial Infections - etiology
Bacterial Infections - therapy
cerebrospinal
Cerebrospinal Fluid Shunts - adverse effects
Child, Preschool
Cohort Studies
Female
Guideline Adherence - statistics & numerical data
Humans
Infant
Infant, Newborn
infection
Male
Pediatrics
Postoperative Complications - etiology
Postoperative Complications - therapy
Prospective Studies
shunt
treatment
title Variability in Management of First Cerebrospinal Fluid Shunt Infection: A Prospective Multi-Institutional Observational Cohort Study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T22%3A57%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variability%20in%20Management%20of%20First%20Cerebrospinal%20Fluid%20Shunt%20Infection:%20A%20Prospective%20Multi-Institutional%20Observational%20Cohort%20Study&rft.jtitle=The%20Journal%20of%20pediatrics&rft.au=Simon,%20Tamara%20D.,%20MD,%20MSPH&rft.aucorp=Hydrocephalus%20Clinical%20Research%20Network%20(HCRN)&rft.date=2016-12-01&rft.volume=179&rft.spage=185&rft.epage=191.e2&rft.pages=185-191.e2&rft.issn=0022-3476&rft.eissn=1097-6833&rft_id=info:doi/10.1016/j.jpeds.2016.08.094&rft_dat=%3Cproquest_pubme%3E1835390520%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1835390520&rft_id=info:pmid/27692463&rft_els_id=1_s2_0_S0022347616308770&rfr_iscdi=true